Performance of Fanfilcon A Toric Lenses After at Least One Month Wearing Enfilcon A Toric Lenses

Sponsor
Coopervision, Inc. (Industry)
Overall Status
Completed
CT.gov ID
NCT02921412
Collaborator
(none)
37
4
2
5.6
9.3
1.6

Study Details

Study Description

Brief Summary

This is a prospective, multi-center, subject-masked, bilateral, daily wear, two-month dispensing study

Condition or Disease Intervention/Treatment Phase
  • Device: fanfilcon A
N/A

Detailed Description

The aim of this study is to determine if adapted contact lens wearers enfilcon A toric lenses can be confidently refit into fanfilcon A toric lenses and can be successful after one month of daily wear.

Study Design

Study Type:
Interventional
Actual Enrollment :
37 participants
Allocation:
Non-Randomized
Intervention Model:
Single Group Assignment
Masking:
Single (Participant)
Primary Purpose:
Treatment
Official Title:
Performance of Fanfilcon A Toric Lenses After at Least One Month Wearing Enfilcon A Toric Lenses
Actual Study Start Date :
Oct 1, 2016
Actual Primary Completion Date :
Feb 1, 2017
Actual Study Completion Date :
Mar 21, 2017

Arms and Interventions

Arm Intervention/Treatment
No Intervention: enfilcon A (habitual)

All participants wear enfilcon A toric lens (habitual) and then refitted with fanfilcon A toric lenses.

Active Comparator: fanfilcon A

All participants wear enfilcon A toric lens (habitual) and then refitted with fanfilcon A toric lenses.

Device: fanfilcon A
contact lens

Outcome Measures

Primary Outcome Measures

  1. Visual Acuity [baseline, 2 weeks, 1 month]

    High contrast distance visual acuity is measured by LogMAR.

  2. Centration [baseline, 2 weeks, 1 month]

    Lens centration is assessed (optimum, decentration acceptable, decentration unacceptable).

  3. Corneal Coverage [baseline, 2 weeks, 1 month]

    Corneal coverage will be assessed (yes/no)

  4. Post-blink Movement [baseline, 2 weeks, 1 month]

    Post-blink lens movement assessed using the following evaluations (0-4): 0=Insufficient, unacceptable, 1=Minimal, acceptable, 2=Optimal, 3=Moderate, acceptable, 4=Excessive, unacceptable)

  5. Fit Acceptability [baseline, 2 weeks, 1 month]

    Investigator fit acceptability for each lens pair. Scale 0-4: (0=should not be worn, 1=borderline but unacceptable, 2=minimally acceptable, early review, 3=not perfect but OK to dispense, 4=perfect)

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 40 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
A person is eligible for inclusion in the study if he/she:
  • Is between 18 and 40 years of age (inclusive)

  • Has had a self-reported eye exam in the last two years

  • Is a habitual soft toric lens wearer

  • Can be successfully fit with study lenses (≥ grade 2 fit acceptance)

  • Has a contact lens spherical prescription between -1.00 to -6.00D with a cylinder between -0.75 and -1.75D (Diopters) (inclusive)

  • Has a spectacle cylinder of at least 0.75D in each eye.

  • Can achieve best corrected spectacle refraction distance visual acuity of 20/25 (0.10 logMAR) or better in each eye.

  • Can achieve a distance visual acuity of 20/30 (0.18 logMAR) or better in each eye with the study contact lenses.

  • Has clear corneas and no active ocular disease

  • Has read, understood and signed the information consent letter

  • Has a contact lens refraction that fits within the available parameters of the study lenses

  • Is willing to comply with the wear schedule (at least 5 days per week, > 8 hours/day assuming there are no contraindications for doing so)

  • Is willing to comply with the visit schedule.

Exclusion Criteria:
A person will be excluded from the study if he/she:
  • Has a history of not achieving comfortable CL (Contact Lens) wear (5 days per week; > 8 hours/day)

  • Presents with clinically significant anterior segment abnormalities

  • Presents with ocular or systemic disease or need of medications which might interfere with contact lens wear

  • Presents with slit lamp findings that would contraindicate contact lens wear such as:

  • Pathological dry eye or associated findings

  • Significant pterygium, pinguecula, or corneal scars within the visual axis

  • Neovascularization > 0.75 mm in from of the limbus

  • Anterior uveitis or iritis (or history in past year)

  • Seborrheic eczema of eyelid region, Seborrheic conjunctivitis

  • History of corneal ulcers or fungal infections

  • Poor personal hygiene

  • Has a known history of corneal hypoesthesia (reduced corneal sensitivity)

  • Has aphakia, keratoconus or a highly irregular cornea.

  • Has presbyopia or has dependence on spectacles for near work over the contact lenses.

  • Has undergone corneal refractive surgery.

  • Is participating in any other type of eye related clinical or research study.

  • Is frequently using rewetting/ lubricating eye drops (more than once per day)

Contacts and Locations

Locations

Site City State Country Postal Code
1 Hospital Contact Lens Service Miami Florida United States 33136
2 Debbie Kim Closter New Jersey United States 07624
3 West Village Eyecare New York New York United States 10014
4 Spokane Eye Clinic Spokane Washington United States 99204

Sponsors and Collaborators

  • Coopervision, Inc.

Investigators

None specified.

Study Documents (Full-Text)

More Information

Publications

None provided.
Responsible Party:
Coopervision, Inc.
ClinicalTrials.gov Identifier:
NCT02921412
Other Study ID Numbers:
  • EX-MKTG-67
First Posted:
Oct 3, 2016
Last Update Posted:
Apr 10, 2018
Last Verified:
Mar 1, 2018
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Additional relevant MeSH terms:

Study Results

Participant Flow

Recruitment Details
Pre-assignment Detail 37 participants were initially enrolled (assigned a study ID), with 1 failing the screening. A total of 36 participants wore the control lens (enfilcon A toric) first and then refitted and dispensed the test lenses (fanfilcon A toric) at baseline visit. There were no discontinuations.
Arm/Group Title All Participants (Enfilcon A Toric / Fanfilcon A Toric Lenses)
Arm/Group Description All participants wore enfilcon A toric lens (habitual) and then wore fanfilcon A toric lenses for 1 month.
Period Title: Overall Study
STARTED 36
COMPLETED 36
NOT COMPLETED 0

Baseline Characteristics

Arm/Group Title Enfilcon A Toric / Fanfilcon A Toric
Arm/Group Description All participants wear enfilcon A toric lens (habitual) and then refitted with fanfilcon A toric lenses at baseline visit.
Overall Participants 36
Age (years) [Mean (Standard Deviation) ]
Mean (Standard Deviation) [years]
29.4
(6.7)
Sex: Female, Male (Count of Participants)
Female
25
69.4%
Male
11
30.6%
Race and Ethnicity Not Collected (Count of Participants)
Region of Enrollment (Count of Participants)
United States
36
100%

Outcome Measures

1. Primary Outcome
Title Visual Acuity
Description High contrast distance visual acuity is measured by LogMAR.
Time Frame baseline, 2 weeks, 1 month

Outcome Measure Data

Analysis Population Description
Analysis was performed prior to one participant completing the 2 week and 1 month visits.
Arm/Group Title Enfilcon A Toric (Baseline) Fanfilcon A Toric (Dispense) Fanfilcon A Toric (2 Weeks) Fanfilcon A Toric (1 Month)
Arm/Group Description All participants wear enfilcon A toric lens (habitual) and then refitted with fanfilcon A toric lenses at baseline visit. All participants wear enfilcon A toric lens (habitual) and then refitted with fanfilcon A toric lenses at baseline visit. All participants wear enfilcon A toric lens (habitual) and then refitted with fanfilcon A toric lenses at baseline visit. All participants wear enfilcon A toric lens (habitual) and then refitted with fanfilcon A toric lenses at baseline visit.
Measure Participants 36 36 35 35
Mean (Standard Deviation) [logMAR]
-0.05
(0.05)
-0.05
(0.05)
-0.05
(0.05)
-0.04
(0.04)
2. Primary Outcome
Title Centration
Description Lens centration is assessed (optimum, decentration acceptable, decentration unacceptable).
Time Frame baseline, 2 weeks, 1 month

Outcome Measure Data

Analysis Population Description
Analysis was performed prior to one participant completing the 2 week and 1 month visits.
Arm/Group Title Enfilcon A Toric (Baseline) Fanfilcon A Toric (Dispense) Fanfilcon A Toric (2 Weeks) Fanfilcon A Toric (1 Month)
Arm/Group Description All participants wear enfilcon A toric lens (for 1 month) and then refitted with fanfilcon A toric lenses at baseline visit. All participants wear enfilcon A toric lens (for 1 month) and then refitted with fanfilcon A toric lenses at baseline visit. All participants wear enfilcon A toric lens (for 1 month) and then refitted with fanfilcon A toric lenses at baseline visit. All participants wear enfilcon A toric lens (for 1 month) and then refitted with fanfilcon A toric lenses at baseline visit.
Measure Participants 36 36 35 35
Optimum
34
94.4%
35
NaN
30
NaN
33
NaN
Acceptable
1
2.8%
1
NaN
5
NaN
2
NaN
Unacceptable
1
2.8%
0
NaN
0
NaN
0
NaN
3. Primary Outcome
Title Corneal Coverage
Description Corneal coverage will be assessed (yes/no)
Time Frame baseline, 2 weeks, 1 month

Outcome Measure Data

Analysis Population Description
Analysis was performed prior to one participant completing the 2 week and 1 month visits.
Arm/Group Title Enfilcon A Toric (Baseline) Fanfilcon A Toric (Dispense) Fanfilcon A Toric (2 Weeks) Fanfilcon A Toric (1 Month)
Arm/Group Description All participants wear enfilcon A toric lens (habitual) and then refitted with fanfilcon A toric lenses at baseline visit. All participants wear enfilcon A toric lens (habitual) and then refitted with fanfilcon A toric lenses at baseline visit. All participants wear enfilcon A toric lens (habitual) and then refitted with fanfilcon A toric lenses at baseline visit. All participants wear enfilcon A toric lens (habitual) and then refitted with fanfilcon A toric lenses at baseline visit.
Measure Participants 36 36 35 35
Yes
36
100%
36
NaN
35
NaN
35
NaN
No
0
0%
0
NaN
0
NaN
0
NaN
4. Primary Outcome
Title Post-blink Movement
Description Post-blink lens movement assessed using the following evaluations (0-4): 0=Insufficient, unacceptable, 1=Minimal, acceptable, 2=Optimal, 3=Moderate, acceptable, 4=Excessive, unacceptable)
Time Frame baseline, 2 weeks, 1 month

Outcome Measure Data

Analysis Population Description
Analysis was performed prior to one participant completing the 2 week and 1 month visits.
Arm/Group Title Enfilcon A Toric (Baseline) Fanfilcon A Toric (Dispense) Fanfilcon A Toric (2 Weeks) Fanfilcon A Toric (1 Month)
Arm/Group Description All participants wear enfilcon A toric lens (habitual) and then refitted with fanfilcon A toric lenses at baseline visit. All participants wear enfilcon A toric lens (habitual) and then refitted with fanfilcon A toric lenses at baseline visit. All participants wear enfilcon A toric lens (habitual) and then refitted with fanfilcon A toric lenses at baseline visit. All participants wear enfilcon A toric lens (habitual) and then refitted with fanfilcon A toric lenses at baseline visit.
Measure Participants 36 36 35 35
Mean (Standard Deviation) [units on a scale]
1.83
(0.51)
1.92
(0.50)
1.69
(0.47)
1.86
(0.49)
5. Primary Outcome
Title Fit Acceptability
Description Investigator fit acceptability for each lens pair. Scale 0-4: (0=should not be worn, 1=borderline but unacceptable, 2=minimally acceptable, early review, 3=not perfect but OK to dispense, 4=perfect)
Time Frame baseline, 2 weeks, 1 month

Outcome Measure Data

Analysis Population Description
Analysis was performed prior to one participant completing the 2 week and 1 month visits.
Arm/Group Title Enfilcon A Toric (Baseline) Fanfilcon A Toric (Dispense) Fanfilcon A Toric (2 Weeks) Fanfilcon A Toric (1 Month)
Arm/Group Description All participants wear enfilcon A toric lens (habitual) and then refitted with fanfilcon A toric lenses at baseline visit. All participants wear enfilcon A toric lens (habitual) and then refitted with fanfilcon A toric lenses at baseline visit. All participants wear enfilcon A toric lens (habitual) and then refitted with fanfilcon A toric lenses at baseline visit. All participants wear enfilcon A toric lens (habitual) and then refitted with fanfilcon A toric lenses at baseline visit.
Measure Participants 36 36 35 35
Mean (Standard Deviation) [units on a scale]
3.3
(0.6)
3.3
(0.5)
3.1
(0.8)
3.1
(0.6)

Adverse Events

Time Frame Adverse event data collected at all scheduled visits over a 1 month period of time
Adverse Event Reporting Description
Arm/Group Title All Participants (Enfilcon A Toric / Fanfilcon A Toric Lenses)
Arm/Group Description All participants wore enfilcon A toric lenses (habitual) and then refitted with fanfilcon A toric lenses at baseline visit.
All Cause Mortality
All Participants (Enfilcon A Toric / Fanfilcon A Toric Lenses)
Affected / at Risk (%) # Events
Total 0/36 (0%)
Serious Adverse Events
All Participants (Enfilcon A Toric / Fanfilcon A Toric Lenses)
Affected / at Risk (%) # Events
Total 0/36 (0%)
Other (Not Including Serious) Adverse Events
All Participants (Enfilcon A Toric / Fanfilcon A Toric Lenses)
Affected / at Risk (%) # Events
Total 0/36 (0%)

Limitations/Caveats

[Not Specified]

More Information

Certain Agreements

Principal Investigators are NOT employed by the organization sponsoring the study.

Disclosure restriction on the PI is that the sponsor should be notified of any results communications and has ability to review.

Results Point of Contact

Name/Title Jose Vega, O.D., MSc., FAAO
Organization CooperVision
Phone 9256213761
Email JVega2@coopervision.com
Responsible Party:
Coopervision, Inc.
ClinicalTrials.gov Identifier:
NCT02921412
Other Study ID Numbers:
  • EX-MKTG-67
First Posted:
Oct 3, 2016
Last Update Posted:
Apr 10, 2018
Last Verified:
Mar 1, 2018